ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Est. Return 169.78%
This Quarter Est. Return
1 Year Est. Return
+169.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$71.6M
AUM Growth
-$14.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1
+$2.62M
2
+$1.77M
3
+$1.12M
4
AKRO icon
Akero Therapeutics
AKRO
+$1.06M
5
TERN icon
Terns Pharmaceuticals
TERN
+$516K

Top Sells

1
+$6.94M
2
+$5.22M
3
+$2.29M
4
MRK icon
Merck
MRK
+$2.06M
5
OCUL icon
Ocular Therapeutix
OCUL
+$1.9M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$2.59B
$9.42M 13.15%
1,014,940
-204,784
CDTX icon
2
Cidara Therapeutics
CDTX
$2.59B
$8.75M 12.21%
179,569
+53,861
WHWK
3
Whitehawk Therapeutics
WHWK
$123M
$6.38M 8.9%
3,410,402
SLNO icon
4
Soleno Therapeutics
SLNO
$3.61B
$5.31M 7.42%
63,436
-3,700
TRML icon
5
Tourmaline Bio
TRML
$1.23B
$4.54M 6.33%
283,682
-143,200
ASND icon
6
Ascendis Pharma
ASND
$12.5B
$3.9M 5.44%
22,576
-764
INSM icon
7
Insmed
INSM
$34.5B
$3.73M 5.21%
37,070
-69,004
ARGX icon
8
argenx
ARGX
$51.6B
$3.69M 5.16%
6,702
-321
PRAX icon
9
Praxis Precision Medicines
PRAX
$3.42B
$3.12M 4.35%
74,087
-13,054
JAZZ icon
10
Jazz Pharmaceuticals
JAZZ
$8.14B
$2.79M 3.89%
26,283
+16,708
TRVI icon
11
Trevi Therapeutics
TRVI
$1.29B
$2.7M 3.77%
493,735
-292,226
OCS icon
12
Oculis Holding
OCS
$1.13B
$2.07M 2.89%
106,718
-18,282
RVMD icon
13
Revolution Medicines
RVMD
$9.29B
$2.05M 2.86%
55,693
-10,969
BBOT
14
BridgeBio Oncology
BBOT
$903M
$1.99M 2.78%
187,257
TERN icon
15
Terns Pharmaceuticals
TERN
$753M
$1.73M 2.42%
463,864
+138,314
SRZN icon
16
Surrozen
SRZN
$117M
$1.52M 2.12%
170,000
DRUG
17
Bright Minds Biosciences
DRUG
$471M
$1.27M 1.77%
48,474
-11,274
TSHA icon
18
Taysha Gene Therapies
TSHA
$1.39B
$1.12M 1.57%
+485,669
AKRO icon
19
Akero Therapeutics
AKRO
$4.3B
$1.06M 1.47%
+19,772
ZYME icon
20
Zymeworks
ZYME
$1.4B
$1.05M 1.47%
83,655
+15,196
LQDA icon
21
Liquidia Corp
LQDA
$2B
$945K 1.32%
75,876
-77,606
RARE icon
22
Ultragenyx Pharmaceutical
RARE
$3.27B
$866K 1.21%
23,814
+2,524
VSTM icon
23
Verastem
VSTM
$585M
$624K 0.87%
150,414
-25,586
FULC icon
24
Fulcrum Therapeutics
FULC
$503M
$410K 0.57%
+59,650
UNCY icon
25
Unicycive Therapeutics
UNCY
$87.1M
$300K 0.42%
62,899
-172,390
1
2